- Home
- TIRX vs SNSE Comparison
TIRX vs SNSE Comparison
Compare TIRX & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TIRX | SNSE |
|---|---|---|
| Founded | 2010 | 2005 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5M | 12.2M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TIRX | SNSE |
|---|---|---|
| Price | $0.12 | $8.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $72.50 |
| AVG Volume (30 Days) | ★ 93.9M | 60.1K |
| Earning Date | 08-22-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 158.74 | N/A |
| 52 Week Low | $0.07 | $5.00 |
| 52 Week High | $6.45 | $18.35 |
Technical Indicators
Market Signals| Indicator | TIRX | SNSE |
|---|---|---|
| Relative Strength Index (RSI) | 40.97 | 41.55 |
| Support Level | $0.07 | $9.35 |
| Resistance Level | $0.30 | $9.38 |
| Average True Range (ATR) | 0.19 | 1.00 |
| MACD | -0.04 | -0.25 |
| Stochastic Oscillator | 2.08 | 15.22 |
Price Performance
Historical ComparisonAbout TIRX TIAN RUIXIANG Holdings Ltd
Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).